The evolution of the mitochondrial disease diagnostic odyssey
暂无分享,去创建一个
J. Krischer | D. Dimmock | K. Engelstad | R. Buchsbaum | M. Hirano | A. Karaa | J. Thompson | A. Holbert | X. Rosales | Yuelin Long | P. Yeske | Yi Xiao | Hung Pham | Amanda Kramer | Cliff Gorski | Kristin M. Engelstad
[1] E. Ashley,et al. A guide for the diagnosis of rare and undiagnosed disease: beyond the exome , 2022, Genome medicine.
[2] Robert W. Taylor,et al. Mitochondrial disease in adults: recent advances and future promise , 2021, The Lancet Neurology.
[3] P. Chinnery,et al. Mitochondrial Diseases: A Diagnostic Revolution. , 2020, Trends in genetics : TIG.
[4] H. Prokisch,et al. Genetics of mitochondrial diseases: Identifying mutations to help diagnosis , 2020, EBioMedicine.
[5] W. Hersh,et al. Detecting rare diseases in electronic health records using machine learning and knowledge engineering: Case study of acute hepatic porphyria , 2020, medRxiv.
[6] Marni J. Falk,et al. Mitochondrial diseases in North America , 2020, Neurology: Genetics.
[7] M. Reilly,et al. Next-generation sequencing in Charcot–Marie–Tooth disease: opportunities and challenges , 2019, Nature Reviews Neurology.
[8] S. Parikh,et al. Harmonizing care for rare diseases: How we developed the mitochondrial care network in the United States. , 2019, Molecular genetics and metabolism.
[9] Marni J. Falk,et al. Mitochondrial disease patient motivations and barriers to participate in clinical trials , 2018, PloS one.
[10] M. Hirano,et al. Diagnostic odyssey of patients with mitochondrial disease , 2018, Neurology: Genetics.
[11] G. Comi,et al. Congenital myopathies: clinical phenotypes and new diagnostic tools , 2017, Italian Journal of Pediatrics.
[12] G. Matthijs,et al. Congenital disorders of glycosylation (CDG): Quo vadis? , 2017, European journal of medical genetics.
[13] R. Myers,et al. Genomic diagnosis for children with intellectual disability and/or developmental delay , 2016, bioRxiv.
[14] Robert W. Taylor,et al. Prevalence of nuclear and mitochondrial DNA mutations related to adult mitochondrial disease , 2015, Annals of neurology.
[15] Marni J. Falk,et al. Diagnosis and management of mitochondrial disease: a consensus statement from the Mitochondrial Medicine Society , 2014, Genetics in Medicine.
[16] J. Krischer,et al. The Rare Diseases Clinical Research Network Contact Registry update: features and functionality. , 2012, Contemporary clinical trials.
[17] Robert W. Taylor,et al. A neurological perspective on mitochondrial disease , 2010, The Lancet Neurology.
[18] Guido Davidzon,et al. Mitochondrial DNA and disease , 2005, Annals of medicine.
[19] A. Schapira,et al. Mitochondrial disorders: an overview. , 1997, Journal of bioenergetics and biomembranes.
[20] Manuel Posada de la Paz,et al. Preparing for the Future of Rare Diseases. , 2017, Advances in experimental medicine and biology.
[21] Hilde van der Togt,et al. Publisher's Note , 2003, J. Netw. Comput. Appl..